Showing results (811-820 of 3,636) with videos related to

Sort By:
Pageof 364
Breast (Edinburgh, Scotland)|February 18, 2024
Interactive multidisciplinary pilot workshop to improve medical student perception of and interest in breast surgical oncologyAmani Raheel, Shreeya Dalla, Jalee Birney, et al.
Breast (Edinburgh, Scotland)|February 17, 2024
21-gene recurrence score in predicting the outcome of postoperative radiotherapy in T1-2N1 luminal breast cancer after breast-conserving surgeryShang-Jin Xie, Run-Jie Wang, San-Gang Wu, et al.
Breast (Edinburgh, Scotland)|February 15, 2024
Is circulating tumor cell count-driven cost-effective for first-line therapy choice in HR+/HER2- metastatic breast cancer in the United States?Huiting Lin, Wenhua Wu, Xiaoya Lou, et al.
Breast (Edinburgh, Scotland)|March 17, 2024
Gender minorities in breast cancer - Clinical trials enrollment disparities: Focus on male, transgender and gender diverse patientsFederica Miglietta, Letizia Pontolillo, Carmine De Angelis, et al.
Breast (Edinburgh, Scotland)|April 2, 2024
Outcomes of atypical (B3) core biopsy lesions diagnosed across BreastScreen NSW, AustraliaRichard Chou, Diana Tran, Joseph Descallar, et al.
Breast (Edinburgh, Scotland)|April 11, 2024
Global representativeness and impact of funding sources in cost-effectiveness research on systemic therapies for advanced breast cancer: A systematic reviewFelippe Lazar Neto, Marina Acevedo Zarzar de Melo, Cassio Murilo Trovo Hidalgo Filho, et al.
Breast (Edinburgh, Scotland)|September 5, 2024
Metronomic chemotherapy using capecitabine and cyclophosphamide in metastatic breast cancer - efficacy, tolerability and quality of life results from the phase II METRO trialKarolina Larsson, Jamila Adra, Leif Klint, et al.
Breast (Edinburgh, Scotland)|October 15, 2024
Chemotherapy in older patients with early breast cancerMarcus Schmidt, Sibylle Loibl
Breast (Edinburgh, Scotland)|October 3, 2024
Breast-cancer specific comprehensive archive of Patient-Reported Outcome Measures (PROMs) for clinical research and clinical practice in oncology: Results from the PRO4All projectAnna Amela Valsecchi, Filippo Giovanardi, Francesco Malandrini, et al.
Breast (Edinburgh, Scotland)|August 8, 2024
Olaparib plus trastuzumab in HER2-positive advanced breast cancer patients with germline BRCA1/2 mutations: The OPHELIA phase 2 studyJosé Enrique Alés-Martínez, Judith Balmaña, Pedro Sánchez-Rovira, et al.
Pageof 364